Skip to main content

Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients

The Original Article was published on 06 January 2021

Correction to: Zhen et al. Antimicrob Resist Infect Control (2021) 10:5 https://0-doi-org.brum.beds.ac.uk/10.1186/s13756-020-00872-w

The original article [1] mistakenly omitted an acknowledgement on behalf of co-author, Nina Zhu. The amended Acknowledgement section ahead displays the full Acknowledgements statement for this article:

Acknowledgements

We want to thank the Center for Health Policy Studies, School of Medicine, Zhejiang University for the assistance in primary data collection. Co-author NZ is funded by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London in partnership with Public Health England (PHE), in collaboration with Imperial College Health Partners, University of Cambridge and University of Warwick. NZ gratefully acknowledges the support of ESRC as part of the Antimicrobial Cross Council initiative supported by the seven UK research councils, and also the support of the Global Challenges Research Fund. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health and Social Care or Public Health England.

Reference

  1. Zhen X, et al. Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrob Resist Infect Control. 2021;10:5. https://0-doi-org.brum.beds.ac.uk/10.1186/s13756-020-00872-w.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hengjin Dong.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhen, X., Lundborg, C.S., Sun, X. et al. Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrob Resist Infect Control 10, 64 (2021). https://0-doi-org.brum.beds.ac.uk/10.1186/s13756-021-00934-7

Download citation

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13756-021-00934-7